Evidence that glucagon stimulates insulin secretion through its own receptor in rats

Diabetologia. 1995 Mar;38(3):274-6. doi: 10.1007/BF00400630.

Abstract

Since glucagon-like peptide-1 (7-36) amide (7-37) (GLP-1) has been found to be a potent insulinotropic hormone, it has been postulated that glucagon stimulates insulin secretion from islet beta cells through the GLP-1 receptor. We therefore examined the effects of a GLP-1 receptor antagonist, exendin (9-39) amide, on glucagon- or GLP-1-stimulated insulin release from isolated perfused rat pancreas. When infusion of 100 nmol/l exendin (9-39) amide was started 5 min before that of 1 nmol/l glucagon, the stimulation of insulin release by glucagon was similar to that found in the control situation (preinfusion with vehicle alone). By contrast, when 0.3 nmol/l GLP-1 was used in the same experimental setting, exendin (9-39) amide clearly inhibited insulin release. These results indicate that glucagon stimulates insulin release mainly through glucagon receptors but not GLP-1 receptors on islet beta cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Glucagon / pharmacology*
  • Glucagon-Like Peptide 1
  • Glucagon-Like Peptide-1 Receptor
  • In Vitro Techniques
  • Insulin / metabolism*
  • Insulin Secretion
  • Islets of Langerhans / drug effects
  • Islets of Langerhans / metabolism*
  • Kinetics
  • Male
  • Peptide Fragments / pharmacology*
  • Perfusion
  • Protein Precursors / pharmacology*
  • Rats
  • Rats, Wistar
  • Receptors, Glucagon / antagonists & inhibitors
  • Receptors, Glucagon / physiology*
  • Time Factors
  • Venoms / pharmacology

Substances

  • Glp1r protein, rat
  • Glucagon-Like Peptide-1 Receptor
  • Insulin
  • Peptide Fragments
  • Protein Precursors
  • Receptors, Glucagon
  • Venoms
  • exendin (9-39)
  • Glucagon-Like Peptide 1
  • Glucagon